Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 100, Issue 9, 2006, Pages 831-837

  Valecha, Neena ^a   Joshi, Hema ^a   Eapen, Alex ^a   Ravinderan, John ^a   Kumar, Ashwani ^a   Prajapati, Surendra Kumar ^a   Ringwald, Pascal ^b  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Chloroquine; Drug resistance; India; Malaria; Plasmodium vivax; Sulfadoxine pyrimethamine

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DIHYDROFOLATE REDUCTASE; PROTOZOAL DNA; PYRIMETHAMINE; SULFONAMIDE;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; CLEARANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; FEMALE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; IN VITRO STUDY; INDIA; MAJOR CLINICAL STUDY; MALARIA; MALE; MUTATIONAL ANALYSIS; PARASITE ISOLATION; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PRURITUS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT FAILURE; TYPHOID FEVER; VOMITING;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; FEMALE; GENES, PROTOZOAN; GENOTYPE; HUMANS; INDIA; MALARIA, VIVAX; MALE; MUTATION; PLASMODIUM VIVAX; PROSPECTIVE STUDIES; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 33745590429     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2005.11.012     Document Type: Article

References (21)

1. Ahmed A., Bararia D., Vinayak S., Yameen M., Biswas S., Dev V., Kumar A., Ansari M.A., and Sharma Y.D. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. Antimicrob. Agents Chemother. 48 (2004) 879-889
2. Baird J.K. Chloroquine resistance in Plasmodium vivax. Antimicrob. Agents Chemother. 48 (2004) 4075-4083
3. Baird J.K. Effectiveness of antimalarial drugs. N. Engl. J. Med. 352 (2005) 1565-1577
4. Darlow B., Vrbova H., Gibney S., Jolley D., Stace J., and Alpers M. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children of Papua New Guinea. II. Plasmodium vivax. Am. J. Trop. Med. Hyg. 31 (1982) 10-13
5. Dua V.K., Kar P.K., and Sharma V.P. Chloroquine resistant Plasmodium vivax malaria in India. Trop. Med. Int. Health 1 (1996) 816-819
6. Garavelli P.L., and Corti E. Chloroquine resistance in Plasmodium vivax: the first case in Brazil. Trans. R. Soc. Trop. Med. Hyg. 86 (1992) 128
7. Garg M., Gopinathan N., Bodhe P., and Kshirsagar N.A. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans. R. Soc. Trop. Med. Hyg. 89 (1995) 656-657
8. Hastings M.D., Porter K.M., Maguire J.D., Susanti I., Kania W., Bangs M.J., Sibley C.H., and Baird J.K. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine. J. Infect. Dis. 189 (2004) 744-750
9. Imwong M., Pukrittakayamee S., Looareesuwan S., Pasvol G., Poirriez J., White N.J., and Snounou G. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob. Agents Chemother. 45 (2001) 3122-3127
10. Korsinczky M., Fischer K., Chen N., Baker J., Rieckmann K., and Cheng Q. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site. Antimicrob. Agents Chemother. 48 (2004) 2214-2222
11. Kshirsagar N.A., Gogtay N.J., Rajgor D., Dalvi S.S., and Wakde M. An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay). India. Ann. Trop. Med. Parasitol. 94 (2000) 189-190
12. Murphy G.S., Basri H., Purnomo, Andersen E.M., Bangs M.J., Mount D.L., Gorden J., Lal A.A., Purwokusumo A.R., Harjosuwarno S., Sorensen K., and Hoffman S.L. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 341 (1993) 96-100
13. Myat-Phone-Kyaw, Myint-Oo, Myint-Lwin, Thaw-Zin, Kyin-Hla-Aye, and Nwe-Nwe-Yin. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans. R. Soc. Trop. Med. Hyg. 87 (1993) 687
14. Nandy A., Addy M., Maji A.K., and Bandyopdhaya A.K. Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India. Ann. Trop. Med. Parasitol. 97 (2003) 215-220
15. Pukrittayakamee S., Chantra A., Simpson J.A., Vanijanonta S., Clemens R., Looareeswan S., and White N.J. Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob. Agents Chemother. 44 (2000) 1680-1685
16. Rieckmann K.H., Davis D.R., and Hutton D.C. Plasmodium vivax resistance to chloroquine?. Lancet 18 (1989) 1183-1184
17. Schuurkamp G.J., Spicer P.E., Kereu R.K., Bulungol P.K., and Rieckmann K.H. Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg. 86 (1992) 121-122
18. Schwartz I.K., Lackritz E.M., and Patchen L.C. Chloroquine-resistant Plasmodium vivax from Indonesia. N. Engl. J. Med. 324 (1991) 927
19. Singh R.K. Emergence of chloroquine-resistant vivax malaria in South Bihar (India). Trans. R. Soc. Trop Med. Hyg. 94 (2000) 327
20. Tjitra E., Baker J., Suprianto S., Cheng Q., and Anstey N.M. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to P. vivax dhfr mutations. Antimicrob. Agents Chemother. 46 (2002) 3947-3953
21. WHO, 2002. Monitoring antimalarial drug resistance. Report of a WHO consultation. World Health Organization, Geneva, WHO/CDS/RBM/2002.39, pp. 1-29.